Biomarkers for Alzheimer's disease diagnosis

V Mantzavinos, A Alexiou - Current Alzheimer Research, 2017 - ingentaconnect.com
Objective: The dramatic increase in the population with dementia expected in the next
decades is accompanied by the establishment of novel and innovated methods that will offer …

Alzheimer's disease: a review from the pathophysiology to diagnosis, new perspectives for pharmacological treatment

P dos Santos, C Leide, PF Ozela… - Current medicinal …, 2018 - ingentaconnect.com
Dementia is characterized by the impairment of cognition and behavior of people over 65
years. Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder in the …

Metabolism: a novel shared link between diabetes mellitus and Alzheimer's disease

Y Sun, C Ma, H Sun, H Wang, W Peng… - Journal of diabetes …, 2020 - Wiley Online Library
As a chronic metabolic disease, diabetes mellitus (DM) is broadly characterized by elevated
levels of blood glucose. Novel epidemiological studies demonstrate that some diabetic …

[HTML][HTML] The association of tau with mitochondrial dysfunction in Alzheimer's disease

Y Cheng, F Bai - Frontiers in neuroscience, 2018 - frontiersin.org
Increasing evidence suggests that abnormally hyperphosphorylated tau plays a vital role in
the pathogenesis of Alzheimer's disease (AD). Mitochondrial dysfunction also has a …

[HTML][HTML] A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease

E Area-Gomez, A de Groof, E Bonilla… - Cell death & …, 2018 - nature.com
In the last few years, increased emphasis has been devoted to understanding the
contribution of mitochondria-associated endoplasmic reticulum (ER) membranes (MAM) to …

[HTML][HTML] Mitochondrial dysfunction in Alzheimer's disease and the rationale for bioenergetics based therapies

IG Onyango, J Dennis, SM Khan - Aging and disease, 2016 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is a debilitating neurodegenerative disorder characterized by the
progressive loss of cholinergic neurons, leading to the onset of severe behavioral, motor …

Diabetes and Alzheimer's disease crosstalk

D Baglietto-Vargas, J Shi, DM Yaeger, R Ager… - Neuroscience & …, 2016 - Elsevier
Despite intensive research efforts over the past few decades, the mechanisms underlying
the etiology of sporadic Alzheimer's disease (AD) remain unknown. This fact is of major …

[HTML][HTML] Neuronal gene targets of NF-κB and their dysregulation in Alzheimer's disease

WM Snow, BC Albensi - Frontiers in molecular neuroscience, 2016 - frontiersin.org
Although, better known for its role in inflammation, the transcription factor nuclear factor
kappa B (NF-κB) has more recently been implicated in synaptic plasticity, learning, and …

[HTML][HTML] A reciprocal relationship between reactive oxygen species and mitochondrial dynamics in neurodegeneration

CHL Hung, SSY Cheng, YT Cheung, S Wuwongse… - Redox biology, 2018 - Elsevier
Mitochondrial fragmentation due to fission/fusion imbalance has often been linked to
mitochondrial dysfunction and apoptosis in neurodegeneration. Conventionally, it is …

Low-level laser therapy for beta amyloid toxicity in rat hippocampus

Y Lu, R Wang, Y Dong, D Tucker, N Zhao… - Neurobiology of …, 2017 - Elsevier
Beta amyloid (Aβ) is well accepted to play a central role in the pathogenesis of Alzheimer's
disease (AD). The present work evaluated the therapeutic effects of low-level laser …